Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma
- 1 December 2001
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 7 (4) , 279-283
- https://doi.org/10.1007/bf03032384
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the MessageJournal of Clinical Oncology, 2001
- HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe International Journal of Cell Cloning, 1998
- The role of stereotactic biopsy in assessment of nonpalpable breast lesionsThe American Journal of Surgery, 1996
- Stereotactic breast biopsy is accurate, minimally invasive, and cost effectiveThe American Journal of Surgery, 1996
- The neu-protein and breast cancerVirchows Archiv, 1995
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986